ecancer

COVID-19: The situation in Florida and managing lung cancer patients

Dr. Luis Raez - Memorial Healthcare System, Florida, Miami

27 Apr 2020

New oncogenic drivers in NSCLC

Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands

23 Apr 2020

The potential of KRAS inhibitors for non-small-cell lung cancer

Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany

22 Apr 2020

COVID-19: The management of coronavirus patients with cancer, examples from Italy

Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy

31 Mar 2020

Management of mutation-negative NSCLC

Dr Vijay Patil - Tata Medical Center, Kolkata, India

6 Mar 2020

Systematic therapy of driver mutated NSCLC

Dr Vijay Patil - Tata Medical Center, Kolkata, India

6 Mar 2020

Loco-regionally advanced NSCLC: Radiation oncologist's perspective

Prof Simon Pavamani - Christian Medical College, Vellore, India

6 Mar 2020

Node-positive NSCLC: A surgeons point of view

Dr Robin Thambudorai- Tata Medical Center, Kolkata, India

6 Mar 2020

Working up metastatic NSCLC

Dr Depak Dabkara - Tata Medical Center, Kolkata, India

6 Mar 2020

Treatment of early stage adenocarcinoma

Dr C S Pramesh - Tata Memorial Hospital, Mumbai, India

20 Feb 2020

Choosing wisely: Lung adenocarcinoma

Dr Navneet Singh - Post Graduate Institute of Medical Education & Research, Chandigarh, India

18 Feb 2020

Diagnosis and staging of lung adenocarcinoma

Dr Navneet Singh - Government Medical College and Hospital, Chandigarh, India

13 Feb 2020

More from ecancer